Luther King Capital Management (LKCM)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-44,163
| Closed | -$2.63M | – | 565 |
|
|
2020
Q3 | $2.63M | Sell |
44,163
-1,114
| -2% | -$66.2K | 0.02% | 228 |
|
|
2020
Q2 | $3.16M | Sell |
45,277
-2,220
| -5% | -$155K | 0.02% | 200 |
|
|
2020
Q1 | $2.16M | Sell |
47,497
-4,536
| -9% | -$206K | 0.02% | 214 |
|
|
2019
Q4 | $3.39M | Buy |
52,033
+23,844
| +85% | +$1.55M | 0.02% | 215 |
|
|
2019
Q3 | $1.75M | Sell |
28,189
-13,537
| -32% | -$840K | 0.01% | 290 |
|
|
2019
Q2 | $2.97M | Sell |
41,726
-425
| -1% | -$30.3K | 0.02% | 225 |
|
|
2019
Q1 | $3.31M | Buy |
42,151
+10,468
| +33% | +$821K | 0.03% | 207 |
|
|
2018
Q4 | $2.68M | Sell |
31,683
-521
| -2% | -$44.1K | 0.02% | 223 |
|
|
2018
Q3 | $5.52M | Sell |
32,204
-1,411
| -4% | -$242K | 0.04% | 181 |
|
|
2018
Q2 | $4.34M | Buy |
33,615
+3,054
| +10% | +$395K | 0.04% | 196 |
|
|
2018
Q1 | $3.15M | Buy |
+30,561
| New | +$3.15M | 0.03% | 230 |
|